These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15955803)

  • 1. Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens.
    Pashov A; Canziani G; Monzavi-Karbassi B; Kaveri SV; Macleod S; Saha R; Perry M; Vancott TC; Kieber-Emmons T
    J Biol Chem; 2005 Aug; 280(32):28959-65. PubMed ID: 15955803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity.
    Pashov AD; Plaxco J; Kaveri SV; Monzavi-Karbassi B; Harn D; Kieber-Emmons T
    J Biol Chem; 2006 Oct; 281(40):29675-83. PubMed ID: 16899462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting carbohydrate antigens in HIV vaccine development.
    Pashov A; Canziani G; Macleod S; Plaxco J; Monzavi-Karbassi B; Kieber-Emmons T
    Vaccine; 2005 Mar; 23(17-18):2168-75. PubMed ID: 15755589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
    Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
    Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming characteristics of peptide mimotopes of carbohydrate antigens.
    Monzavi-Karbassi B; Shamloo S; Kieber-Emmons M; Jousheghany F; Luo P; Lin KY; Cunto-Amesty G; Weiner DB; Kieber-Emmons T
    Vaccine; 2003 Jan; 21(7-8):753-60. PubMed ID: 12531355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directing the immune response to carbohydrate antigens.
    Cunto-Amesty G; Dam TK; Luo P; Monzavi-Karbassi B; Brewer CF; Van Cott TC; Kieber-Emmons T
    J Biol Chem; 2001 Aug; 276(32):30490-8. PubMed ID: 11384987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens.
    Luo P; Agadjanyan M; Qiu J; Westerink MA; Steplewski Z; Kieber-Emmons T
    Mol Immunol; 1998 Sep; 35(13):865-79. PubMed ID: 9839555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease.
    Bermas BL; Petri M; Berzofsky JA; Waisman A; Shearer GM; Mozes E
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1071-7. PubMed ID: 7826694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.
    Zhang H; Fu H; Luallen RJ; Liu B; Lee FH; Doms RW; Geng Y
    Vaccine; 2015 Sep; 33(39):5140-7. PubMed ID: 26277072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1.
    Cruz LJ; Iglesias E; Aguilar JC; Cabrales A; Reyes O; Andreu D
    Bioconjug Chem; 2004; 15(5):1110-7. PubMed ID: 15366967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
    Dorgham K; Dogan I; Bitton N; Parizot C; Cardona V; Debré P; Hartley O; Gorochov G
    AIDS Res Hum Retroviruses; 2005 Jan; 21(1):82-92. PubMed ID: 15665647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining carbohydrate antigens as HIV vaccine candidates.
    Pashov A; Perry M; Dyar M; Chow M; Kieber-Emmons T
    Curr Pharm Des; 2007; 13(2):185-201. PubMed ID: 17269927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120.
    Bolmstedt A; Olofsson S; Sjögren-Jansson E; Jeansson S; Sjöblom I; Akerblom L; Hansen JE; Hu SL
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3099-105. PubMed ID: 1281869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies.
    Kim YB; Han DP; Cao C; Cho MW
    Virology; 2003 Jan; 305(1):124-37. PubMed ID: 12504547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The barley lectin, horcolin, binds high-mannose glycans in a multivalent fashion, enabling high-affinity, specific inhibition of cellular HIV infection.
    Jayaprakash NG; Singh A; Vivek R; Yadav S; Pathak S; Trivedi J; Jayaraman N; Nandi D; Mitra D; Surolia A
    J Biol Chem; 2020 Aug; 295(34):12111-12129. PubMed ID: 32636304
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody responses to the HIV-1 envelope high mannose patch.
    Daniels CN; Saunders KO
    Adv Immunol; 2019; 143():11-73. PubMed ID: 31607367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules.
    VanCott TC; Bethke FR; Kalyanaraman V; Burke DS; Redfield RR; Birx DL
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1103-15. PubMed ID: 7523653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.